Cargando…

Novel Therapeutic Targets in the Brain Tumor Microenvironment

Glioblastoma (GBM), a highly malignant brain tumor of adults and children, diffusely invades within the non-neoplastic brain. Despite aggressive current therapeutic interventions, improved therapeutic strategies are greatly needed. Interactions between the tumor and constituents of its microenvironm...

Descripción completa

Detalles Bibliográficos
Autor principal:	Phillips, Joanna J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Research Perspectives
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3388186/ https://www.ncbi.nlm.nih.gov/pubmed/22643827

Ejemplares similares

Expanding horizons in overcoming therapeutic resistance in castration-resistant prostate cancer: targeting the androgen receptor-regulated tumor immune microenvironment
por: Cheng, Bisheng, et al.
Publicado: (2023)

Proposal to Consider Chemical/Physical Microenvironment as a New Therapeutic Off-Target Approach
por: Giuliani, Alessandro, et al.
Publicado: (2022)

Pancreatic cancer microenvironment, to target or not to target?
por: Carr, Ryan M, et al.
Publicado: (2016)

Modeling the tumor immune microenvironment for drug discovery using 3D culture
por: Lee, Joanna Y., et al.
Publicado: (2021)

Novel Therapeutic Targets for Tumor Microenvironment in Cancer
por: Bei, Roberto, et al.
Publicado: (2023)

ULK1 as a novel therapeutic target in neurodegeneration
por: Vahsen, Björn Friedhelm, et al.
Publicado: (2020)

Single-cell RNA-Seq unveils tumor microenvironment
por: Lee, Hae-Ock, et al.
Publicado: (2017)

Evolution-driven crosstalk between glioblastoma and the tumor microenvironment
por: Wu, Lingxiang, et al.
Publicado: (2023)

Progress in mimicking brain microenvironments to understand and treat neurological disorders
por: Ngo, Mai T., et al.
Publicado: (2021)

Lipid metabolism in tumor microenvironment: novel therapeutic targets
por: Liu, Xingkai, et al.
Publicado: (2022)

Involvement of lncRNAs in the tumor microenvironment: a new property of tumor immunity
por: Lin, Qingyu, et al.
Publicado: (2023)

Microparticles as Novel Biomarkers and Therapeutic Targets in Coronary Heart Disease
por: Zhou, Bo-Da, et al.
Publicado: (2015)

Free ubiquitin: a novel therapeutic target for neurodegenerative diseases
por: Park, Chul-Woo, et al.
Publicado: (2021)

The extended renin-angiotensin system: a promising target for traumatic brain injury therapeutics
por: Janatpour, Zachary C., et al.
Publicado: (2019)

Advances in landscape and related therapeutic targets of the prostate tumor microenvironment: Therapeutic targets of the prostate tumor microenvironment
por: Li, Duocai, et al.
Publicado: (2023)

The kallikrein-kinin system: a promising therapeutic target for traumatic brain injury
por: Hopp, Sarah, et al.
Publicado: (2015)

Targeting microthrombosis and neuroinflammation with vepoloxamer for therapeutic neuroprotection after traumatic brain injury
por: Xiong, Ye, et al.
Publicado: (2018)

Targeting neuroinflammation after therapeutic hypothermia for perinatal hypoxic-ischemic brain injury
por: Zhou, Kelly Q., et al.
Publicado: (2022)

Recent research hotspots in sequencing and the pancreatic neuroendocrine tumor microenvironment
por: Xu, Junfeng, et al.
Publicado: (2023)

Chitinase 3-like-1, a novel regulator of Th1/CTL responses, as a therapeutic target for increasing anti-tumor immunity
por: Kim, Do-Hyun, et al.
Publicado: (2018)

Consequences of hepatic damage after traumatic brain injury: current outlook and potential therapeutic targets
por: Villapol, Sonia
Publicado: (2016)

The emerging world of subcellular biological medicine: extracellular vesicles as novel biomarkers, targets, and therapeutics
por: Coleman, Leon G.
Publicado: (2021)

High mobility group box-1 protein as a therapeutic target in perinatal hypoxic-ischemic brain injury
por: Hatayama, Kazuki, et al.
Publicado: (2021)

Influencing cognitive performance via social interactions: a novel therapeutic approach for brain disorders based on neuroanatomical mapping?
por: Lanooij, Suzanne D., et al.
Publicado: (2022)

Pomalidomide-induced changes in the pancreatic tumor microenvironment and potential for therapy
por: Storz, Peter
Publicado: (2019)

Astrocytic Kir4.1 potassium channels as a novel therapeutic target for epilepsy and mood disorders
por: Ohno, Yukihiro
Publicado: (2018)

Targeting De Novo Lipogenesis and Cholesterol Biosynthesis Simultaneously is a Novel Therapeutic Option for Hepatocellular Carcinoma
por: Liu, Qian, et al.
Publicado: (2021)

Shifting balance from neurodegeneration to regeneration of the brain: a novel therapeutic approach to Alzheimer's disease and related neurodegenerative conditions
por: Iqbal, Khalid, et al.
Publicado: (2014)

Cancer Stem Cells Therapeutic Target Database: The First Comprehensive Database for Therapeutic Targets of Cancer Stem Cells
por: Hu, Xiaoqing, et al.
Publicado: (2016)

Exosomes: Emerging Players of Intercellular Communication in Tumor Microenvironment
por: Maheshwari, Shrankhla, et al.
Publicado: (2014)

New unexpected role for Wolfram Syndrome protein WFS1: a novel therapeutic target for Alzheimer’s disease?
por: Chen, Shuo, et al.
Publicado: (2022)

Therapeutic Targeting of MicroRNAs in the Tumor Microenvironment
por: Raue, Rebecca, et al.
Publicado: (2021)

Therapeutic Targets and Tumor Microenvironment in Colorectal Cancer
por: Gallo, Gaetano, et al.
Publicado: (2021)

Epigenetic regulation and therapeutic targets in the tumor microenvironment
por: Xie, Zhuojun, et al.
Publicado: (2023)

Cognitive Decline Secondary to Therapeutic Brain Radiation—Similarities and Differences to Traumatic Brain Injury
por: Huang, Andrew Jonathan, et al.
Publicado: (2019)

The tumor vasculature an attractive CAR T cell target in solid tumors
por: Akbari, Parvin, et al.
Publicado: (2019)

Rapid onset brain plasticity at novel pharmacologic targets hypothetically drives innovations for rapid onset antidepressant actions
por: Cooper, Takesha, et al.
Publicado: (2023)

Extracellular vesicles as novel carriers for therapeutic molecules
por: Yim, Nambin, et al.
Publicado: (2016)

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence
por: Molejon, Maria Inés, et al.
Publicado: (2015)

OPA1 Dominant Optic Atrophy: Pathogenesis and Therapeutic Targets
por: Wong, David C. S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bsrvj03u5qagbqdinjo8p77ehb